Aspirin reduces the risk Cancer

The regular use of aspirin would reduce by almost 60% risk of cancer, including colon, according to a study by British scientists.

A discovery at the very least surprising. We knew quite effective against aspirin pain but not to the point of a weapon of cancer detection. However, British researchers have just proven the correlation between regular dosing schedule and partial prevention of colorectal cancer and other organs. According to the study published in the international journal Lancet, the results are very positive. "Finally we have shown that aspirin has a significant preventive effect on cancer, but it only becomes clear after a few years," nuance, however, Professor John Burn, director of research.

A historic step forward?
The scientist in question have conducted this research in 16 countries on 861 patients with Lynch syndrome, a genetic defect that causes the bowel cancer. Half the patients received two tablets of aspirin per day. The other half swallowed a placebo. The result is instructive. In 2010, 19 bowel cancers were diagnosed in the first group against 34 in the second. In an interview with the Telegraph, John Burn says that "if we give them an aspirin now, we should avoid 10,000 cancers over the next 30 years."

Aspirin at a glance
Acetylsalicylic acid, or aspirin, is the drug most consumed in the world. 2450 packets per second are consumed. This amounts to a total weight of 40,000 tons per year, 80 billion tablets.